Hillhouse-backed Chinese biopharmaceutical firm JHBP (CY) Holdings Limited, also known as Genor Biopharma, has filed for an initial public offering (IPO) on the Main Board of the Hong Kong Stock Exchange (HKEX) to raise about HK$2.48 billion ($320 million).
Continue reading this premium story with a subscription to DealStreetAsia.Subscribe
Already a Subscriber? Log in
Contact us for corporate subscriptions at email@example.com